Celebrating 20 Years of IP Excellence

Court Cranks the Clock Back on Opposed Crankshaft Patent Refusal

Court Cranks the Clock Back on Opposed Crankshaft Patent Refusal

The Madras High Court remanded Pinnacle Engines Inc.’s patent application for their opposed piston engine, addressing inventive features overlooked by the Assistant Controller of Patents. The court emphasized the significance of the crank offset and opposite crankshaft rotation in reducing friction and vibration, directing a reassessment by a different officer. Continue Reading Court Cranks the Clock Back on Opposed Crankshaft Patent Refusal

Read more

Patent on Portable Vehicle Management System goes offtrack

Patent on Portable Vehicle Management System goes offtrack

The Delhi High Court confirmed the refusal of Mahesh Gupta’s patent application for a Portable Vehicle Management System, citing the lack of an inventive step in light of prior arts D4 and D5. The decision underscores important principles of patentability, including mosaicing, hindsight bias, and the criteria for non-obviousness. Continue Reading Patent on Portable Vehicle Management System goes offtrack

Read more

PATENT AND TRADEMARK AGENT EXAMINATIONS 2025 - DATES ANNOUNCED

Announcement: Patent and Trademark Agent Examinations 2025 by Indian IP Office

The Office of the Controller General of Patents, Designs & Trade Marks (CGPDTM) has released the schedule for the Trade Marks Agent Examination and Patent Agent Examination for 2025. These examinations are crucial for individuals aiming to become registered intellectual property agents. The exams will take place in various cities across India on 4th and 5th January 2025. Continue Reading Announcement: Patent and Trademark Agent Examinations 2025 by Indian IP Office

Read more

‘Controller under an obligation to inform inventor’ says Madras High Court

‘Controller under an obligation to inform inventor’ says Madras High Court

This post examines two crucial orders from the Madras High Court regarding patent refusals, highlighting the necessity for Controllers to provide detailed and well-reasoned orders. The cases of Nihon Onkyo Engineering Co. Ltd. and Qualcomm Incorporated demonstrate the importance of clarity in refusal decisions to facilitate judicial review and ensure transparency. Continue Reading ‘Controller under an obligation to inform inventor’ says Madras High Court

Read more

Delhi High Court Reverses Patent Office Decision: Honeywell's Amendments Upheld

Delhi High Court Reverses Patent Office Decision: Honeywell’s Amendments Upheld

The Delhi High Court ruled in favor of Honeywell International Inc., overturning a refusal order by the Patent Office. The court emphasized the importance of fairness and the consideration of claims in conjunction with complete specifications, setting a precedent for thorough examination in patent matters. Continue Reading Delhi High Court Reverses Patent Office Decision: Honeywell’s Amendments Upheld

Read more

Image accompanying blogpost on "Inventive Step Assessment: To be Anchored in Knowledge of a Person with Ordinary Skill on the Priority Date"

Inventive Step Assessment: To be Anchored in Knowledge of a Person with Ordinary Skill on the Priority Date

The Delhi High Court overturned the patent refusal for Alimentary Health’s probiotic formulation, emphasizing the need for an objective analysis of inventive step under the Patents Act, 1970. The Court criticized the Patent Office’s decision and highlighted the importance of avoiding hindsight bias in evaluating patent applications. Continue Reading Inventive Step Assessment: To be Anchored in Knowledge of a Person with Ordinary Skill on the Priority Date

Read more

High Court of Himachal Pradesh grants Boehringer Ingelheim an interim injunction against Eris Lifesciences for patent infringement of diabetes drug Empagliflozin

Boehringer secures Patent Injunction for its Diabetes Drug – Empagliflozin

On May 30, 2024, the High Court of Himachal Pradesh granted an interim injunction to Boehringer Ingelheim, restraining Eris Lifesciences from manufacturing, selling, or marketing Empagliflozin tablets due to patent infringement. The court emphasized the importance of maintaining scientific integrity and upheld the validity of Boehringer’s patent. Continue Reading Boehringer secures Patent Injunction for its Diabetes Drug – Empagliflozin

Read more

Connect with Us

BananaIP Counsels

No.40, 3rd Main Road, JC Industrial Estate, Kanakapura Road, Bangalore – 560 062.

Telephone: +91-76250 93758+91-80-49536207 | +91-80-26860414/24/34
Email: contact@bananaip.com

Please enable JavaScript in your browser to complete this form.
Checkboxes

© 2004-2024 BananaIP Counsels. All Rights Reserved.